No Detail Found!

Post splenectomy protein C levels in beta thalassaemia major patients

Author(s)
Awais Niaz Department of Pathology, Al Nafees Medical College and Hospital, Islamabad, Pakistan
Kiran Tauseef 2Department of Pathology, Rawal Institute of Health Sciences, Islamabad, Pakistan
Mudassira Zahid Department of Pathology, Rawalpindi Medical University, Rawalpindi, Pakistan
Humaira Zafar 1Department of Pathology, Al Nafees Medical College and Hospital, Islamabad, Pakistan
Asma Nafisa Department of Pathology, Rawalpindi Medical University, Rawalpindi, Pakistan
Nadeem Ikram Department of Pathology, Rawalpindi Medical University, Rawalpindi, Pakistan
Abstract
Objectives: To compare protein C levels with splenectomy status in beta-TM patients. Methodology: Cross-sectional comparative study conducted in the Department of Pathology, Al-Nafees Medical College & Hospital, Islamabad in collaboration with the Thalassemia center of Pakistan Institute of Medical Sciences, and Islamabad Diagnostic Center, Islamabad. After written informed consent, 60 diagnosed beta-thalassemia major patients were enrolled based upon inclusion and exclusion criteria, there were 30 splenectomized and 30 non-splenectomized patients. Protein C levels were measured by chromogenic assay. The mean values of protein C were compared between splenectomized and nonsplenectomized beta-TM patients by student's t-test. Pearson correlation test was done to find the correlation between protein C and serum Ferritin, ALT, and serum albumin. A p-Value < 0.05 was considered statistically significant. Results:The mean protein C values in non-splenectomized and splenectomized patients were 62.11±9.65% and 41.64±6.37% respectively with a significant difference by independent samples t-test (p=0.000).There were 45% (n=27) male and 55% (n=33) female patients. The mean age for the selected patients was 12.95 ± 5.43 years. The mean protein C activity in all thalassemia patients was 51.87 % ± 13.12. The mean protein C activity in non-splenectomized patients was 62.11 % ± 9.66. Conclusion: Splenectomy in thalassemia increases the risk of hypercoagulability and thromboembolic complications. Splenectomized beta-TM patients have decreased protein C activity as compared to non-splenectomized beta-TM patients, signifying decreased activity of anticoagulant mechanisms.
Publication Details
Page(s) 85-89
DOI DOI not available
Published Journal: Journal of Haematology and Stem Cell Research, Volume: 2, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
Protein C, anticoagulant, Splenectomized, Beta thalassemia major, Hypercoagulability, Non-splenectomized.
0

Citations

0

Downloads

47

Views